|
BEIJING, March 23, 2026 /PRNewswire/ -- Robotics company ROBOTERA has closed a strategic funding round of RMB 1 billion, pushing its valuation past RMB 10 billion. The round saw participation from major new investors including Gaocheng Capital, Singtel Innov8, Woori Venture Partners (subsidiary of Woori Financial Holdings), CICC Porsche Fund, China Fortune-Tech Capital, Fenghe Capital, Wuxi Capital, GF QIANHE, Horizon Investment, and a leading South Korean technology company, with existing investors CDH Venture and Growth Capital and Tsinghua Holding Tiancheng Asset Management significantly increasing their stakes.
In total, ROBOTERA has secured 16 domestic and international industrial investors, spanning sectors including technology, automotive, logistics, consumer electronics, semiconductors, new energy, new materials, and telecommunications. The investor base features domestic leaders such as Geely Capital, Alibaba, Lenovo, Haier Capital, BAIC, and Golden Resources Group, alongside global giants including Singtel Innov8, Woori Capital, and a leading South Korean technology company forming a strong and broad industrial ecosystem.
Notably, this funding round comes just two months after ROBOTERA's previous round, with the committed investment far exceeding the initial fundraising target.
Fully In-House Hardware Expertise
ROBOTERA has long maintained fully in-house hardware development. Leveraging proprietary motors, reducers, and joint modules, the company's full size bipedal humanoid robot L7 has achieved world records in high jump and long jump, demonstrating advanced electromechanical design and motion control capabilities. In 2024, ROBOTERA launched the world's first direct-drive dexterous hand, achieving about 70% of human-level efficiency in logistics operations; as a standalone product, over 1,000 units were shipped in 2025, 50% to overseas markets.
Commercial Deployment and Order Growth
With fully in-house hardware and industrial partnerships, ROBOTERA's commercial rollout shows high market adoption and repeat orders. To date, cumulative orders have exceeded RMB 500 million, 50% from international clients, including nine of the world's top 10 publicly listed tech companies, some placing repeat orders up to six times.
In logistics, the company has deployed robotic solutions in Shenzhen, Huzhou, Hangzhou, Hefei, and Beijing, achieving operational efficiencies of up to 70% in some scenarios. Collaborating with SF Express, ROBOTERA launched a cross-border logistics inspection solution, which has been officially deployed at customs, with single orders exceeding RMB 50 million—signaling a move from pilot projects to large-scale delivery.
Looking Ahead
Beyond logistics, industrial clients include Samsung, Geely, Renault, Lenovo, Haier, TCL, and Century Golden Resources, spanning 3C, automotive, and high-end manufacturing sectors. The newly raised funds will accelerate technology iteration and product scale-up, with a focus on e-commerce logistics, industrial manufacturing, and pharmaceutical distribution. ROBOTERA aims to advance the deployment of robots in industrial applications, leveraging its technological expertise and industry partnerships to strengthen competitiveness in both domestic and international markets.
BEIJING, March 23, 2026 /PRNewswire/ -- Robotics company ROBOTERA has closed a strategic funding round of RMB 1 billion, pushing its valuation past RMB 10 billion. The round saw participation from major new investors including Gaocheng Capital, Singtel Innov8, Woori Venture Partners (subsidiary of Woori Financial Holdings), CICC Porsche Fund, China Fortune-Tech Capital, Fenghe Capital, Wuxi Capital, GF QIANHE, Horizon Investment, and a leading South Korean technology company, with existing investors CDH Venture and Growth Capital and Tsinghua Holding Tiancheng Asset Management significantly increasing their stakes.
In total, ROBOTERA has secured 16 domestic and international industrial investors, spanning sectors including technology, automotive, logistics, consumer electronics, semiconductors, new energy, new materials, and telecommunications. The investor base features domestic leaders such as Geely Capital, Alibaba, Lenovo, Haier Capital, BAIC, and Golden Resources Group, alongside global giants including Singtel Innov8, Woori Capital, and a leading South Korean technology company forming a strong and broad industrial ecosystem.
Notably, this funding round comes just two months after ROBOTERA's previous round, with the committed investment far exceeding the initial fundraising target.
Fully In-House Hardware Expertise
ROBOTERA has long maintained fully in-house hardware development. Leveraging proprietary motors, reducers, and joint modules, the company's full size bipedal humanoid robot L7 has achieved world records in high jump and long jump, demonstrating advanced electromechanical design and motion control capabilities. In 2024, ROBOTERA launched the world's first direct-drive dexterous hand, achieving about 70% of human-level efficiency in logistics operations; as a standalone product, over 1,000 units were shipped in 2025, 50% to overseas markets.
Commercial Deployment and Order Growth
With fully in-house hardware and industrial partnerships, ROBOTERA's commercial rollout shows high market adoption and repeat orders. To date, cumulative orders have exceeded RMB 500 million, 50% from international clients, including nine of the world's top 10 publicly listed tech companies, some placing repeat orders up to six times.
In logistics, the company has deployed robotic solutions in Shenzhen, Huzhou, Hangzhou, Hefei, and Beijing, achieving operational efficiencies of up to 70% in some scenarios. Collaborating with SF Express, ROBOTERA launched a cross-border logistics inspection solution, which has been officially deployed at customs, with single orders exceeding RMB 50 million—signaling a move from pilot projects to large-scale delivery.
Looking Ahead
Beyond logistics, industrial clients include Samsung, Geely, Renault, Lenovo, Haier, TCL, and Century Golden Resources, spanning 3C, automotive, and high-end manufacturing sectors. The newly raised funds will accelerate technology iteration and product scale-up, with a focus on e-commerce logistics, industrial manufacturing, and pharmaceutical distribution. ROBOTERA aims to advance the deployment of robots in industrial applications, leveraging its technological expertise and industry partnerships to strengthen competitiveness in both domestic and international markets.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
ROBOTERA Raises RMB 1 Billion in Strategic Round, Valuation Exceeds RMB 10 Billion with Broad Industry Support
The evolution of a 10-year R&D heritage that previously swept top US luxury department stores. Meet Dr.BRID C, the next-generation biotech skincare line launching on Amazon—all under $25.
NEW YORK and SEOUL, South Korea, March 23, 2026 /PRNewswire/ -- Altitude 40,000 feet. Humidity below 20%. If you've ever looked in the mirror after a long-haul flight to find your skin rough, red, and completely parched, this new beauty brand's origin story will instantly resonate with you.
Born out of the desperate need for VIPs and beauty professionals to protect their skin in harsh, Sahara-like cabin environments, the next-generation biotech K-beauty brand Dr.BRID C has officially launched on US Amazon.
The 'Paradox of Beauty': How We're Destroying Our Own Skin
Even on the ground, our skin is under daily attack as if it were 40,000 feet in the air. Air conditioning, pollution, and ironically, our daily beauty routines—heavy makeup, harsh double-cleansing, and chemical exfoliation—are slowly stripping away our skin barrier.
To break this vicious cycle, Dr.BRID C goes beyond temporary fixes with a clear and uncompromising philosophy: "Defense Before Beauty."
Luxury Skincare Science That Awakens 'C-Peptide'
Dr.BRID C's barrier-repairing prowess is rooted in a 10-year R&D heritage that previously dominated luxury US department stores like Barneys New York.
Rejecting conventional moisturizers that just suffocate the skin with heavy oils, their scientists developed a proprietary patented technology: PEPTIBRID®. This technology encapsulates a powerful collagen-signaling peptide in soothing zinc oxide, delivering it safely and deeply into the skin. In cell tests, this resulted in a massive 175.3% surge in 'C-peptide,' a key biomarker for new collagen synthesis.
"When trying to create a cream that could help skin survive a 14-hour flight, we realized surface hydration simply wasn't enough," says the Lead Researcher at Dr.BRID C. "Dr.BRID C helps build the fundamental strength skin needs to breathe and defend itself in any extreme environment."
"Balanced and Springy"—Real Customers Prove the Barrier Miracle
Dr.BRID C focuses on rebuilding the skin's core rather than just offering a temporary band-aid. And real customer reviews are already proving the miracle.
An Amazon reviewer who suffered from a compromised oil-water balance and tightness praised the texture and moisture retention: "This cream moisturizer is smooth and makes the skin feel soft after overnight wear without lingering filminess or discomfort. Skin does not feel greasy or oily but balanced and springy."
Furthermore, testers who experienced extreme inner dryness from frequent travel and UV exposure testified to the overwhelming difference: "I have sensitive skin, so after traveling, UV exposure makes my skin reactive and dry... This feels like I've finally found the right cream. It spreads smoothly and absorbs quickly without leaving residue. It addresses inner dryness beautifully."
The #40,000ft Cream Lineup: A Customized Barrier Trio (All Under $25)
Driven by the "Defense Before Beauty" philosophy, the launch centers around three targeted #40,000ft Creams designed for specific skin conditions.
- #40,000ft Barrier Defense Basic Cream ($19.99): The absolute hero of the lineup. Formulated with an optimal 12ppm of PEPTIBRID®, this cream becomes your new daily shield if your oil-water balance has collapsed. It absorbs instantly without any greasiness, creating the perfect velvet canvas for your makeup to grip onto.
- #40,000ft Hydro Relief Cream ($21.99): A cooling gel-cream packed with a high concentration of 21ppm PEPTIBRID® for sensitized, dehydrated skin. Just one use blocks Trans-Epidermal Water Loss (TEWL) by 30.81%, delivering an instant hit of deep hydration.
- #40,000ft Intensive Moisture Basic Cream ($21.99): The ultimate age-defying density care. Boasting 22ppm of PEPTIBRID®—the highest concentration in the lineup—it goes beyond barrier support to visibly improve signs of aging like enlarged pores, rough texture, and eye wrinkles over 8 weeks.
Rounding out the collection is a synergistic, clean-formula lineup—including a pH-balancing toner and a 100-hour moisture-locking serum—all priced under $25. If you're ready to experience cutting-edge barrier defense that survives even the harshest conditions, Dr.BRID C is available now on Amazon(https://www.amazon.com/drbridc?maas=maas_adg_EE29DA495FDC3C85E3F4533006833714_afap_abs&ref_=aa_maas&tag=maas).
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
"It Survived 40,000 Feet, Drier Than the Sahara"--The Ultimate K-Beauty Barrier Cream Just Landed on Amazon
